[1] Arya A K, Hu B. Brain-gut axis after stroke[J]. Brain Circ, 2018, 4(4): 165
[2] Chen Z, Venkat P, Seyfried D, et al. Heart interaction: cardiac complications after stroke[J]. Circ Res, 2017, 121(4): 451
[3] Chen J, Cui C, Yang X, et al. MiR-126 affects brain-heart interaction after cerebral ischemic stroke[J]. Transl Stroke Res, 2017, 8(4): 374
[4] Battaglini D, Robba C, Lopes da Silva A, et al. Brain-heart interaction after acute ischemic stroke[J]. Crit Care,2020, 24(1):163
[5] Arnold J, Ng P, Sims D, et al. Incidence and impact on outcomes of acute kidney injury after a stroke: a systematic review and meta-analysis[J]. BMC Nephrol, 2018, 19(1):283
[6] Kumai Y, Kamouchi M, Hata J, et al. Proteinuria and clinical outcomes after ischemic stroke[J]. Neurology, 2012, 78(24): 1909
[7] Wilson C A, Hatchell D L. Photodynamic retinal vascular thrombosis. Rate and duration of vascular occlusion[J]. Invest Ophthalmol Vis Sci, 1991, 32(8): 235
[8] Zhao T T, Zhang H J, Lu X G, et al. Chaihuang-yishen granule inhibits diabetic kidney disease in rats through blocking TGF-β/Smad3 signaling [J]. PLoS One, 2014, 9(3): e90807.
[9] Castiglione R C, Maron-Gutierrez T, Barbosa C M, et al. Bone marrow-derived mononuclear cells promote improvement in glomerular function in rats with early diabetic nephropathy[J]. Cell Physiol Biochem, 2013, 32(3): 699
[10] Chwojnicki K, Król E, Wierucki L, et al. Renal dysfunction in post-stroke patients[J]. PLoS One, 2016, 11(8): e0159775
[11] Hayden D, McCarthy C, Akijian L, et al. Renal dysfunction and chronic kidney disease in ischemic stroke and transient ischemic attack: A population-based study[J]. Int J Stroke, 2017, 12(7): 761
[12] Tomiyama H, Yamashina A. Clinical considerations for the association between vascular damage and chronic kidney disease[J]. Pulse(Basel), 2014, 2(1-4): 81
[13] Jannot A S, Burgun A, Thervet E, et al. The diagnosis-wide landscape of hospital-acquired AKI[J]. Clin J Am Soc Nephrol, 2017, 12(6):874
[14] Portman R J, Kissane J M, Robson A M, et al. Use of beta 2 microglobulin to diagnose tubulo-interstitial renal lesions in children[J]. Kidney Int, 1986, 30(1): 91
[15] Herrero-Morín J D, Málaga S, Fernández N, et al. Cystatin C and beta2-microglobulin: markers of glomerular filtration in critically ill children[J]. Crit Care,2007, 11(3):R59
[16] Du Y, Zappitelli M, Mian A, et al. Urinary biomarkers to detect acute kidney injury in the pediatric emergency center[J]. Pediatr Nephrol, 2011, 26(2): 267
[17] Shin J R, Kim S M, Yoo J S, et al. Urinary excretion of β 2 -microglobulin as a prognostic marker in immunoglobulin A nephropathy[J]. Korean J Intern Med, 2014, 29(3): 334
[18] Vlasakova K, Erdos Z, Troth S P, et al. Evaluation of the relative performance of 12 urinary biomarkers for renal safety across 22 rat sensitivity and specificity studies [J]. Toxicol Sci, 2014, 138(1): 3
[19] Qian Y, Guo X, Che L, et al. Klotho reduces necroptosis by targeting oxidative stress involved in renal ischemic-reperfusion injury[J]. Cell Physiol Biochem, 2018, 45(6): 2268
[20] He J, Gao H X, Yang N, et al. The aldose reductase inhibitor epalrestat exerts nephritic protection on diabetic nephropathy in db/db mice through metabolic modulation[J]. Acta Pharmacol Sin, 2019, 40(1): 86
[21] Siew E D, Matheny M E. Choice of reference serum creatinine in defining acute kidney injury[J]. Nephron, 2015, 131(2): 107
[22] Lyman J L. Blood urea nitrogen and creatinine[J]. Emerg Med Clin North Am, 1986, 4(2): 223
[23] Zhao Q, Yan T, Chopp M, et al. Brain-kidney interaction: renal dysfunction following ischemic stroke [J]. J Cereb Blood Flow Metab, 2020, 40(2): 246
[24] López-Novoa J M, Rodríguez-Pe?觡a A B, Ortiz A, et al. Etiopathology of chronic tubular, glomerular and renovascular nephropathies: Clinical implications[J]. J Transl Med, 2011, 9(1): 13
[25] Ruiz-Ortega M, Egido J. Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts[J]. Kidney Int, 1997, 52(6): 1497
[26] Castro P, Azevedo E, Rocha I, et al. Chronic kidney disease and poor outcomes in ischemic stroke: Is impaired cerebral autoregulation the missing link[J]. BMC Neurol, 2018, 18(1): 21
[27] Zhang W, Zhou X, Zhang H, et al. Extracellular vesicles in diagnosis and therapy of kidney diseases[J]. Am J Physiol Renal Physiol, 2016, 311(5):F844
[28] Kwon S H. Extracellular vesicles in renal physiology and clinical applications for renal disease[J]. Korean J Intern Med, 2019, 34(3): 470
[1]韩聪聪,李姮,郭兴梅,等.血清胱抑素 c与非瓣膜性房颤患者CHA2DS2-VASc评分的相关性[J].天津医科大学学报,2017,23(03):227.
HAN Cong-cong,LIHeng,GUO Xing-mei,et al.Relationship of cystatin c and CHA2DS2-VASc score in non-valvular atrial fibrillation patients[J].Journal of Tianjin Medical University,2017,23(04):227.
[2]乌日吉木斯,刘啸轩,苏悦,等.白细胞介素-18在小鼠缺血性脑卒中的损伤作用及其机制[J].天津医科大学学报,2021,27(06):603.
WU Ri-jimusi,LIU Xiao-xuan,SU Yue,et al.The injury effect of interleukin-18 in the mice with ischemic stroke and its mechanism[J].Journal of Tianjin Medical University,2021,27(04):603.
[3]张薇,辛灵,阎涛.AG490改善缺血性脑卒中后神经功能的机制研究[J].天津医科大学学报,2022,28(06):615.
ZHANG Wei,XING Ling,YAN Tao.Mechanism of AG490 improving neurological function after ischemic stroke[J].Journal of Tianjin Medical University,2022,28(04):615.